Core Viewpoint - Anteris Technologies Global Corp. is actively participating in two major healthcare conferences, showcasing its commitment to advancing medical devices for heart function restoration [1][4]. Group 1: Conference Details - Anteris will present at the TD Cowen 46th Annual Healthcare Conference on March 2, 2026, featuring a fireside chat with analyst Joshua Jennings [2]. - The Barclays 28th Annual Healthcare Conference will take place on March 10, 2026, with a fireside chat led by analyst Matt Miksic [3]. - Both conferences will include 1x1 meetings and will be accessible via webcasts, which will be archived for up to 90 days [2][3]. Group 2: Company Overview - Anteris Technologies is a global structural heart company focused on designing and commercializing innovative medical devices [4]. - The company is headquartered in Australia and has a significant operational presence in Minneapolis, USA, emphasizing a science-driven approach [4]. - Anteris' lead product, the DurAVR Transcatheter Heart Valve, is designed to treat aortic stenosis and is the first biomimetic valve, aiming to replicate normal aortic blood flow [5].

Core Viewpoint - Comstock Inc. has opened a new facility in California for recycling end-of-life solar panels, receiving certification from the Department of Toxic Substances Control, positioning itself as a leader in environmentally responsible solar panel recycling in North America [1][2][3] Group 1: Facility and Certification - The new facility in Kings County, CA, is the only certified, zero-landfill solar recycling solution in North America, allowing California companies to recycle end-of-life photovoltaic (PV) modules [1] - The facility has been approved by California's DTSC and is now on a select list of companies authorized to treat PV modules, providing a local solution for recycling [1][2] Group 2: Market Demand and Services - As more solar panels reach the end of their useful life, there is a growing demand for compliant and environmentally responsible recycling solutions in California, Arizona, and Nevada [3] - The facility is designed to serve major utilities, developers, engineering and construction firms, installers, decommissioning contractors, and asset owners, offering a reliable option for managing environmental liabilities [3] Group 3: Strategic Positioning and Future Plans - The California facility enhances Comstock Metals' southwestern recycling network, optimizing logistics to support California's high demand for solar panel recycling [2] - The company is also preparing plans for a second integrated facility in Nevada, with final site selection expected soon, indicating ongoing expansion efforts [4]

Core Viewpoint - The request for the lifting of the suspension of all departments in Nordea Invest is initiated by Nordea Fund Management, a branch of Nordea Funds Oy, Finland [1] Group 1 - The request is formally communicated by Rasmus Eske Bruun, the branch manager of Nordea Fund Management [1]

Core Insights - Allstate Canada reported a significant increase in water-related home insurance claims for 2025, highlighting a gap between risk awareness and preventive measures taken by homeowners [1][2]. Claims Data - Home insurance claims due to external water sources nearly doubled, increasing by 94% in 2025 compared to 2024, with water damage accounting for 24% of all home insurance claims in 2025 [2]. - From 2021 to 2025, water damage represented over 40% of all home insurance claims, with external water sources responsible for nearly one-third (31%) of all water-related claims during this period [2]. Risk Awareness and Prevention - A Léger survey indicated that while many Canadians recognize the risk of flooding, there is a lack of action to mitigate it, with 53% of respondents not planning to take any preventive measures for flooding this spring [3][5]. - Among those planning preventive actions, the most common step is clearing gutters and drains (26%), while only 17% intend to hire professionals for assistance, suggesting a potential underestimation of necessary preventive measures [5]. Recommendations for Homeowners - Allstate Canada encourages homeowners and renters to take proactive steps to reduce flooding risks, such as cleaning gutters, testing sump pumps, and communicating early with landlords about potential issues [4][6]. - Homeowners are advised to review their insurance policies to understand coverage for water damage and identify any gaps in optional coverage [6]. Survey Methodology - The Léger poll was conducted among 1,527 Canadians aged 18 and over, assessing their concerns about flooding and awareness of flood-related insurance coverage [5][7].

Core Insights - Brunswick Corporation has been awarded a Gold BOSS Award, ranking fourth among the top experiential exhibits at CES 2026, highlighting its leadership in marine technology [1] - The awards recognize exhibitors who create immersive, narrative-driven brand environments that enhance technology demonstrations into memorable experiences [2] Company Achievements - Brunswick's exhibit featured innovative elements such as on-water immersion, interactive simulators, and expansive video storytelling, effectively showcasing the company's marine innovations and advanced technologies [2] - The CEO of Brunswick expressed pride in the recognition, emphasizing the company's commitment to advancing marine technology and engaging audiences through compelling storytelling [3] Product Innovations - At CES 2026, Brunswick unveiled several cutting-edge products, including the Sea Ray SLX 360 with Mercury Marine engines and Simrad displays, and the Fliteboard RACE model, showcasing synergies across its business lines [3] Company Overview - Brunswick Corporation is a leader in marine recreation, offering technology-driven solutions informed by consumer insights, and operates over 60 industry-leading brands [4] - The company has approximately 15,000 employees across 26 countries and has been recognized as one of America's Most Trusted Companies by Forbes Magazine [4]

HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today that it has been awarded a major contract by Basra Oil Company (BOC) to provide Integrated Field Management Services (IFMS) for the gigantic Majnoon Oil Field. Located in southern Iraq, Majnoon is one of the world’s largest oil fields, with estimated reserves of over 38 billion barrels. Under the IFMS contract, KBR will provide comprehensive upstream engineering, project and operations management, and maintenance services to enhance ...

Core Viewpoint - TOMI Environmental Solutions, Inc. has received official authorization for its Binary Ionization Technology (BIT) solution and SteraMist iHP brand of disinfection equipment from the Health and Safety Executive (HSE) in Great Britain, marking a significant step for the company's expansion in the UK market [1][2]. Group 1: Product Approval and Market Expansion - The BIT solution is now approved as a biocidal product for use in Great Britain, including England, Scotland, and Wales, under Regulation 528/2012 GB, and also received separate approval for Northern Ireland under Regulation (EU) No. 528/2012 [1][2]. - This approval allows for the BIT solution to be used in room fogging and handheld direct spray applications as a microbial disinfectant across various sectors such as healthcare, industrial, commercial, hospitality, and institutional settings [2][3]. Group 2: Efficacy and Applications - The BIT solution has established efficacy claims in Great Britain, demonstrating effectiveness against bacteria, yeast, and viruses with specific contact times ranging from 5 to 15 minutes depending on the application method [4]. - SteraMist products utilize a low percentage of Hydrogen Peroxide to create a germ-killing aerosol, suitable for a wide range of applications including hospitals, schools, and military facilities [4][5]. Group 3: Company Background and Commitment - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, focusing on indoor surface disinfection through its BIT platform, which was developed under a defense grant in collaboration with DARPA [5][6]. - The company emphasizes its commitment to providing innovative solutions that meet rigorous compliance, safety, and efficacy standards, with optimism for further approvals in the European Union [3][5].

新加坡, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE American: EGG)（以下简称"Enigmatig"或"公司"），今日公布了截至2025年9月30日止财年的经审计财务报告。总收入同比增长12.2%，毛利率提升至68.8%，公司在纽约证券交易所美国板块（NYSE American）上市后整体财务结构更为稳健。公司还宣布，已向美国证券交易委员会（SEC）提交截至2025年9月30日止财年的Form 20-F年度报告。作为全球性商业赋能者，Enigmatig专注于帮助企业实现跨境发展。 2025 财年财务业绩亮点 ●2025财年企业服务总收入450万美元，相较于2024财年的400万美元企业服务总收入，同比增长12.2%。●2025财年销售成本为140万美元，较2024财年的130万美元有所提升。●2025财年整体毛利同比增长14.9%至310 万美元，较2024财年的270 万美元有所提升。●2025财年经营利润为50万美元，2024财年经营利润为100万美元。●2025财年净利润为60万美元，2024财年净利润为80万美元。 ...

Core Viewpoint - Eesti Energia is set to publish its 2025 financial results and interim report on 27 February, with an investor call scheduled for the same day to discuss the results [1] Group 1: Financial Results Announcement - The financial results and interim report will be released on 27 February [1] - The investor call will occur at 11:00 London time, 12:00 Frankfurt time, and 13:00 Tallinn time [1] - The presentation will be conducted in English, followed by a Q&A session [1] Group 2: Participation and Access - Participants are encouraged to submit questions in advance via email to ensure a productive Q&A session [1] - The report and presentation will be available on the Eesti Energia Investor Relations website on the morning of 27 February [1] - A recording and transcript of the call will be published on the same website after the event [1] Group 3: Contact Information - Danel Freiberg is the Head of Treasury and Financial Risk Management at Eesti Energia AS, available for further inquiries [2] - Contact details include a phone number and email address for direct communication [2]

Core Insights - Novo Nordisk announced results from the REDEFINE 4 trial, which investigated the efficacy of CagriSema compared to tirzepatide in individuals with obesity and comorbidities [1][2] Trial Overview - REDEFINE 4 was an 84-week open-label trial involving 809 participants with a mean baseline body weight of 114.2 kg [2] - The trial compared CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) to tirzepatide (15 mg), both administered once weekly [2] Weight Loss Results - Participants treated with CagriSema achieved a weight loss of 23.0% after 84 weeks, compared to 25.5% with tirzepatide [3] - When applying the treatment-regimen estimand, CagriSema resulted in a weight loss of 20.2%, while tirzepatide achieved 23.6% [3] - The trial did not meet its primary endpoint of demonstrating non-inferiority in weight loss for CagriSema compared to tirzepatide [3] Safety Profile - CagriSema exhibited a safe and well-tolerated profile, with the most common adverse events being mild to moderate gastrointestinal issues that diminished over time [4] Future Developments - Novo Nordisk is optimistic about CagriSema's potential as a first GLP-1/amylin-combination product for obesity treatment [5] - The company anticipates an FDA decision on CagriSema for weight management by late 2026, following its submission in December 2025 [5] - Upcoming trials include REDEFINE 11, expected to report data in the first half of 2027, and a higher-dose CagriSema trial planned for the second half of 2026 [5] About CagriSema - CagriSema is a once-weekly subcutaneous treatment being investigated for adults with obesity and type 2 diabetes, combining cagrilintide and semaglutide to reduce hunger and calorie intake [7] About the REDEFINE Programme - The REDEFINE programme is a phase 3 clinical development initiative that includes multiple trials assessing the efficacy and safety of CagriSema in various populations [8][9][10][11][12]